Could a common antidepressant ease the exhaustion of dialysis?
NCT ID NCT06609343
Summary
This study is testing if a medication called bupropion can help reduce the severe fatigue experienced by people with end-stage kidney disease who are on regular dialysis. Sixteen participants will take the pill three times a week during their dialysis sessions for eight weeks. Researchers will measure their tiredness, quality of life, and look for changes in blood markers of inflammation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Dialysis Medical Center (DMC)
San Antonio, Texas, 78229, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.